GLAXOSMITHKLINE PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,888 INR | -0.56% |
|
+0.36% | -0.53% |
| Mar. 22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
| Feb. 29 | Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14% | MT |
Evolution of the average Target Price on GlaxoSmithKline Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
9f3038cbcf49c23a93ab.058ZJ_OrHNYoA2D9EsiE1RVAKLM4rsJ8q1MF8ilwT0k.6sBAQrbodeVwUxKuZbruvywUBetX-LIw7RtEiEU_CDnrxmxDx_NFgFguLQ~dc311da48ef76d07681882311bc633f4
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
1,900
INR
Average target price
2,141
INR
Spread / Average Target
+12.71%
High Price Target
2,450
INR
Spread / Highest target
+28.96%
Low Price Target
1,895
INR
Spread / Lowest Target
-0.26%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- GLAXO Stock
- GLAXO Stock
- Consensus GlaxoSmithKline Pharmaceuticals Limited
